EMA approves Janssen’s Prezista continuous manufacturing line
The EMA has approved Janssen's continuous manufacturing (CM) with real-time release testing for the production of Prezista (darunavir)...
List view / Grid view
News
Nutrition, the microbiome, and Autism Spectrum Disorder: A review
Over the last decade, research has revealed more about the human gut microbiome—the environment within the gastrointestinal tract—where microbes, especially bacteria, reside.
Antibiotic from bacteria found on Kenyan ant could help beat MRSA
A new antibiotic, produced by bacteria found on a species of African ant, is very potent against antibiotic-resistant ‘superbugs’ like MRSA according to scientists.
Wickham Laboratories expands sterility testing capabilities
Wickham Laboratories announces completion of validation on a fourth isolator...
Experts set out plan to tackle “questionable integrity” of medical evidence
A plan to tackle “serious flaws in the creation, dissemination and implementation of medical evidence” is set out by experts from The BMJ and Oxford University’s Centre for Evidence Based Medicine.
Report calls for action to prevent confusion over medicines
The new report highlights the significant difficulties patients and some healthcare professionals face in using evidence from research to judge the benefits and harms of medicines, and calls for concerted action to improve the information patients receive.
UK among top performers in access to healthcare, says new report
The Global Access to Healthcare Index measures how healthcare systems across 60 countries are working to solve the most pressing healthcare needs...
Microfluidics offers superior drug encapsulation
Dolomite Microfluidics is making microencapsulation technology more widely accessible with the Telos® droplet system, designed for high throughput and easy scale up...
Kadcyla new deal means NICE positive recommendation in draft guidance
A new deal on the breast cancer drug trastuzumab emtansine means that it can now be recommended for routine funding.
FDA accepts application for generic version of Advair Diskus
The FDA has accepted Sandoz’s New Drug Application for fluticasone propionate / salmeterol combination product, a generic version of Advair Diskus...
Diabetes drug trial needs to widen participants to understand full impact
More work needs to be done to examine the real world effects of the commonly prescribed diabetes drug empagliflozin, new research finds...
EMA issues guidance document in preparation for Brexit
The European Medicines Agency (EMA) and the European Commission have published guidance to help pharmaceutical companies prepare for the United Kingdom's withdrawal from the European Union.
EMA action plan supports SMEs as drivers of innovation
The European Medicines Agency (EMA) has published an action plan that aims to foster innovation and support small and medium-sized enterprises (SMEs) in the development of novel human and veterinary medicines.
AAM praises Supreme Court Ruling granting access to biosimilars
The Association for Accessible Medicines (AAM) applauded the US Supreme Court’s decision this week in Sandoz Inc. v. Amgen Inc. that will help speed patient access to biosimilar versions of expensive brand-name biologic medicines.
New industry forum to advance clinical trial participation
In 2018, industry leaders from pharma, biotech and clinical research organisations will advance the participation of patients in clinical trials...
